Literature DB >> 30146722

Attenuating M-current suppression in vivo by a mutant Kcnq2 gene knock-in reduces seizure burden and prevents status epilepticus-induced neuronal death and epileptogenesis.

Derek L Greene1, Anastasia Kosenko1, Naoto Hoshi1,2.   

Abstract

OBJECTIVES: The M-current is a low-threshold voltage-gated potassium current generated by Kv7 subunits that regulates neural excitation. It is important to note that M-current suppression, induced by activation of Gq-coupled neurotransmitter receptors, can dynamically regulate the threshold of action-potential firing and firing frequency. Here we sought to directly examine whether M-current suppression is involved in seizures and epileptogenesis.
METHODS: Kv7.2 knock-in mice lacking the key protein kinase C (PKC) phosphorylation acceptor site for M-current suppression were generated by introducing an alanine substitution at serine residue 559 of mouse Kv7.2, mKv7.2(S559A). Basic electrophysiologic properties of the M-current between wild-type and Kv7.2(S559A) knock-in mice were analyzed in primary cultured neurons. Homozygous Kv7.2(S559A) knock-in mice were used to evaluate the protective effect of mutant Kv7.2 channel against chemoconvulsant-induced seizures. In addition, pilocarpine-induced neuronal damage and spontaneously recurrent seizures were evaluated after equivalent chemoconvulsant-induced status epilepticus was achieved by coadministration of the M-current-specific channel inhibitor, XE991. RESULT: Neurons from Kv7.2(S559A) knock-in mice showed normal basal M-currents. Knock-in mice displayed reduced M-current suppression when challenged by a muscarinic agonist, oxotremorine-M. Kv7.2(S559A) mice were resistant to chemoconvulsant-induced seizures with no mortality. Administration of XE991 transiently exacerbated seizures in knock-in mice equivalent to those of wild-type mice. Valproate, which disrupts neurotransmitter-induced M-current suppression, showed no additional anticonvulsant effect in Kv7.2(S559A) mice. After experiencing status epilepticus, Kv7.2(S559A) knock-in mice did not show seizure-induced cell death or spontaneous recurring seizures. SIGNIFICANCE: This study provides evidence that neurotransmitter-induced suppression of M-current generated by Kv7.2-containing channels exacerbates behavioral seizures. In addition, prompt recovery of M-current after status epilepticus prevents subsequent neuronal death and the development of spontaneously recurrent seizures. Therefore, prompt restoration of M-current activity may have a therapeutic benefit for epilepsy. Wiley Periodicals, Inc.
© 2018 International League Against Epilepsy.

Entities:  

Keywords:  zzm321990Kcnq2zzm321990; Kv7.2; epilepsy; kainate; pilocarpine

Mesh:

Substances:

Year:  2018        PMID: 30146722      PMCID: PMC6204291          DOI: 10.1111/epi.14541

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  34 in total

Review 1.  Neuronal KCNQ potassium channels: physiology and role in disease.

Authors:  T J Jentsch
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

2.  Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation.

Authors:  Anastasia Kosenko; Seungwoo Kang; Ida M Smith; Derek L Greene; Lorene K Langeberg; John D Scott; Naoto Hoshi
Journal:  EMBO J       Date:  2012-05-29       Impact factor: 11.598

3.  Distinct enzyme combinations in AKAP signalling complexes permit functional diversity.

Authors:  Naoto Hoshi; Lorene K Langeberg; John D Scott
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

Review 4.  Pathways modulating neural KCNQ/M (Kv7) potassium channels.

Authors:  Patrick Delmas; David A Brown
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

Review 5.  Epileptogenesis in the immature brain: emerging mechanisms.

Authors:  Sanjay N Rakhade; Frances E Jensen
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

6.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

Authors:  H S Wang; Z Pan; W Shi; B S Brown; R S Wymore; I S Cohen; J E Dixon; D McKinnon
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

7.  Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum.

Authors:  Alessandro Alaimo; Juan Camilo Gómez-Posada; Paloma Aivar; Ainhoa Etxeberría; Jose Angel Rodriguez-Alfaro; Pilar Areso; Alvaro Villarroel
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

Review 8.  PIP2 is a necessary cofactor for ion channel function: how and why?

Authors:  Byung-Chang Suh; Bertil Hille
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

9.  M-current preservation contributes to anticonvulsant effects of valproic acid.

Authors:  Hee Yeon Kay; Derek L Greene; Seungwoo Kang; Anastasia Kosenko; Naoto Hoshi
Journal:  J Clin Invest       Date:  2015-09-08       Impact factor: 14.808

10.  Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2.

Authors:  Scott B Hansen; Xiao Tao; Roderick MacKinnon
Journal:  Nature       Date:  2011-08-28       Impact factor: 49.962

View more
  8 in total

1.  In Vivo Attenuation of M-Current Suppression Impairs Consolidation of Object Recognition Memory.

Authors:  Anastasia Kosenko; Shirin Moftakhar; Marcelo A Wood; Naoto Hoshi
Journal:  J Neurosci       Date:  2020-06-17       Impact factor: 6.167

2.  Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity.

Authors:  Simona Musella; Lidia Carotenuto; Nunzio Iraci; Giulia Baroli; Tania Ciaglia; Piera Nappi; Manuela Giovanna Basilicata; Emanuela Salviati; Vincenzo Barrese; Vincenzo Vestuto; Giuseppe Pignataro; Giacomo Pepe; Eduardo Sommella; Veronica Di Sarno; Michele Manfra; Pietro Campiglia; Isabel Gomez-Monterrey; Alessia Bertamino; Maurizio Taglialatela; Carmine Ostacolo; Francesco Miceli
Journal:  J Med Chem       Date:  2022-08-16       Impact factor: 8.039

3.  A Comparison of Epileptogenic Effect of Status Epilepticus Treated With Diazepam, Midazolam, and Pentobarbital in the Mouse Pilocarpine Model of Epilepsy.

Authors:  Xiangzhen Tong; Zizhu Zhang; Jianping Zhu; Shuji Li; Shaogang Qu; Bing Qin; Yanwu Guo; Rongqing Chen
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

4.  Functional responses of the hippocampus to hyperexcitability depend on directed, neuron-specific KCNQ2 K+ channel plasticity.

Authors:  Chase M Carver; Shayne D Hastings; Mileah E Cook; Mark S Shapiro
Journal:  Hippocampus       Date:  2019-10-17       Impact factor: 3.899

5.  The Antagonism of 5-HT6 Receptor Attenuates Current-Induced Spikes and Improves Long-Term Potentiation via the Regulation of M-Currents in a Pilocarpine-Induced Epilepsy Model.

Authors:  Chaofeng Zhu; Rong Lin; Changyun Liu; Mingzhu Huang; Feng Lin; Gan Zhang; Yuying Zhang; Junjie Miao; Wanhui Lin; Huapin Huang
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

Review 6.  Pharmacological Manipulation of K v 7 Channels as a New Therapeutic Tool for Multiple Brain Disorders.

Authors:  Fabio A Vigil; Chase M Carver; Mark S Shapiro
Journal:  Front Physiol       Date:  2020-06-19       Impact factor: 4.566

Review 7.  Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.

Authors:  Deepanjali Dwivedi; Upinder S Bhalla
Journal:  Front Mol Neurosci       Date:  2021-06-03       Impact factor: 5.639

8.  A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment.

Authors:  Mathieu Milh; Pierre Roubertoux; Najoua Biba; Julie Chavany; Adeline Spiga Ghata; Camille Fulachier; Stephan Christopher Collins; Christel Wagner; Jean-Christophe Roux; Binnaz Yalcin; Marie-Solenne Félix; Florence Molinari; Pierre-Pascal Lenck-Santini; Laurent Villard
Journal:  Epilepsia       Date:  2020-04-02       Impact factor: 5.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.